Abstract |
The nucleosides zidovudine (AZT), stavudine ( d4T), and telbivudine (LdT) are approved for use in the treatment of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections. To promote positron emission tomography (PET) imaging studies on their pharmacokinetics, pharmacodynamics, and applications in cancer diagnosis, a convenient one-pot method for Pd(0)-Cu(I) co-mediated rapid C-C coupling of [(11)C] methyl iodide with stannyl precursor was successfully established and applied to synthesize the PET tracers [(11)C] zidovudine, [(11)C] stavudine, and [(11)C] telbivudine. After HPLC purification and radiopharmaceutical formulation, the desired PET tracers were obtained with high radioactivity (6.4-7.0 GBq) and specific radioactivity (74-147 GBq/µmol) and with high chemical (>99%) and radiochemical (>99.5%) purities. This one-pot Pd(0)-Cu(I) co-mediated rapid C-[(11)C]methylation also worked well for syntheses of [methyl-(11)C] thymidine and [methyl-(11)C]4'-thiothymidine, resulting twice the radioactivity of those prepared by a previous two-pot method. The mechanism of one-pot Pd(0)-Cu(I) co-mediated rapid C-[(11)C]methylation was also discussed.
|
Authors | Zhouen Zhang, Hisashi Doi, Hiroko Koyama, Yasuyoshi Watanabe, Masaaki Suzuki |
Journal | Journal of labelled compounds & radiopharmaceuticals
(J Labelled Comp Radiopharm)
Vol. 57
Issue 8
Pg. 540-9
(Jun 30 2014)
ISSN: 1099-1344 [Electronic] England |
PMID | 24992010
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2014 John Wiley & Sons, Ltd. |
Chemical References |
- Carbon Radioisotopes
- Radiopharmaceuticals
- Zidovudine
- Palladium
- Copper
|
Topics |
- Carbon Radioisotopes
(chemistry)
- Catalysis
- Chemistry Techniques, Synthetic
(methods)
- Copper
(chemistry)
- Methylation
- Palladium
(chemistry)
- Radiopharmaceuticals
(chemical synthesis)
- Zidovudine
(analogs & derivatives, chemical synthesis)
|